ANI Pharmaceuticals is building a leading Rare Disease company focused on Serving Patients, Improving Lives

RECENT NEWS

ANI Pharmaceuticals Announces New Fluocinolone Acetonide Intravitreal Implant Data to be Presented at the American Academy of Ophthalmology 2026 Annual Meeting

2026-09-30

READ MORE >

ANI Pharmaceuticals Announces the FDA Approval of Everolimus Tablets for Oral Suspension

2026-09-23

READ MORE >

NASDAQ - ANIP

$72.65

+ 0.03 (0.04%)

Pricing delayed by 20 minutes
Last updated 2026-09-30 16:00:00